{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:45:49Z","timestamp":1775947549936,"version":"3.50.1"},"reference-count":335,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/ejcts\/ezx314","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T07:07:30Z","timestamp":1502435250000},"page":"5-33","source":"Crossref","is-referenced-by-count":335,"title":["2017 EACTS Guidelines on perioperative medication in adult cardiac surgery"],"prefix":"10.1093","volume":"53","author":[{"given":"Miguel","family":"Sousa-Uva*","sequence":"first","affiliation":[]},{"given":"Stuart J","family":"Head","sequence":"additional","affiliation":[]},{"given":"Milan","family":"Milojevic","sequence":"additional","affiliation":[]},{"given":"Jean-Philippe","family":"Collet","sequence":"additional","affiliation":[]},{"given":"Giovanni","family":"Landoni","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Castella","sequence":"additional","affiliation":[]},{"given":"Joel","family":"Dunning","sequence":"additional","affiliation":[]},{"given":"T\u00f3mas","family":"Gudbjartsson","sequence":"additional","affiliation":[]},{"given":"Nick J","family":"Linker","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Sandoval","sequence":"additional","affiliation":[]},{"given":"Matthias","family":"Thielmann","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Jeppsson","sequence":"additional","affiliation":[]},{"given":"Ulf","family":"Landmesser*","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"2025110203540495200_ezx314-B1","first-page":"809","article-title":"Methodology manual for European Association for Cardio-Thoracic Surgery (EACTS) clinical guidelines","volume":"48","author":"Sousa-Uva","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B2","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1161\/CIRCULATIONAHA.112.000337","article-title":"Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial","volume":"128","author":"Kulik","year":"2013","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B3","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/CIRCULATIONAHA.114.014209","article-title":"Efficacy of chronic \u03b2-blocker therapy for secondary prevention on long-term outcomes after coronary artery bypass grafting surgery","volume":"131","author":"Zhang","year":"2015","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jacc.2015.10.043","article-title":"Causes of death following PCI versus CABG in complex CAD: 5-year follow-up of SYNTAX","volume":"67","author":"Milojevic","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025110203540495200_ezx314-B5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jacc.2012.10.018","article-title":"Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention","volume":"61","author":"Hlatky","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203540495200_ezx314-B6","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1093\/eurheartj\/ehw377","article-title":"The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial","volume":"37","author":"Eisen","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ejcts\/ezu366","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"46","author":"Kolh","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B8","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.116.021348","article-title":"Is there a role for cardiac rehabilitation after coronary artery bypass grafting? Treatment after coronary artery bypass surgery remains incomplete without rehabilitation","volume":"133","author":"Niebauer","year":"2016","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa1415447","article-title":"Trial of everolimus-eluting stents or bypass surgery for coronary disease","volume":"372","author":"Park","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.114.013042","article-title":"Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up","volume":"131","author":"Iqbal","year":"2015","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ejcts\/ezx104","article-title":"Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary artery bypass grafting","volume":"52","author":"Milojevic","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejcts.2008.02.024","article-title":"Guideline on antiplatelet and anticoagulation management in cardiac surgery","volume":"34","author":"Dunning","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.athoracsur.2008.11.011","article-title":"The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery","volume":"87","author":"Lazar","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2025110203540495200_ezx314-B15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","article-title":"Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association","volume":"131","author":"Kulik","year":"2015","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ejcts\/ezx324","article-title":"ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"52","author":"Falk","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/ejcts\/ezw313","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"50","author":"Kirchhof","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B18","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B19","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B20","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B22","article-title":"2017 EACTS\/EACTA Guidelines on patient blood management for adult cardiac surgery. The task force on patient blood management for adult cardiac surgery of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Cardiothoracic Anaesthesiology (EACTA)","author":"Pagano","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"Br Med J"},{"key":"2025110203540495200_ezx314-B24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/bja\/aev164","article-title":"Aspirin and coronary artery surgery: a systematic review and meta-analysis","volume":"115","author":"Hastings","year":"2015","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B25","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJMoa1507688","article-title":"Stopping vs. continuing aspirin before coronary artery surgery","volume":"374","author":"Myles","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jtcvs.2012.04.004","article-title":"Effects of preoperative aspirin in coronary artery bypass grafting: a double-blind, placebo-controlled, randomized trial","volume":"144","author":"Deja","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jtcvs.2005.02.041","article-title":"Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism","volume":"130","author":"Morawski","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/eurheartj\/ehn104","article-title":"The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies","volume":"29","author":"Sun","year":"2008","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amjcard.2015.11.040","article-title":"Effect of preoperative aspirin replacement with enoxaparin in patients undergoing primary isolated on-pump coronary artery bypass grafting","volume":"117","author":"Nenna","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025110203540495200_ezx314-B30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/bja\/aet339","article-title":"Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor","volume":"112","author":"Hansson","year":"2014","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/EJA.0000000000000348","article-title":"The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: an in-vitro study","volume":"33","author":"Martin","year":"2016","journal-title":"Eur J Anaesthesiol"},{"key":"2025110203540495200_ezx314-B32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/EJA.0b013e328335b354","article-title":"Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients","volume":"27","author":"Zisman","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"2025110203540495200_ezx314-B33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","article-title":"Aspirin and mortality from coronary bypass surgery","volume":"347","author":"Mangano","year":"2002","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1569-9293(03)00181-6","article-title":"Does aspirin 6\u2009h after coronary artery bypass grafting optimise graft patency?","volume":"2","author":"Musleh","year":"2003","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203540495200_ezx314-B35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B36","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B37","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B38","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/eurheartj\/ehr422","article-title":"Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"32","author":"Becker","year":"2011","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B39","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B40","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203540495200_ezx314-B41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jacc.2012.03.030","article-title":"Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis","volume":"60","author":"Smith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203540495200_ezx314-B42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/eurheartj\/ehv381","article-title":"Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study","volume":"37","author":"Hansson","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/ejcts\/ezw149","article-title":"Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment","volume":"50","author":"Tomsic","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B44","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1592\/phco.28.3.376","article-title":"Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting","volume":"28","author":"Pickard","year":"2008","journal-title":"Pharmacotherapy"},{"key":"2025110203540495200_ezx314-B45","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/hrt.2004.058396","article-title":"Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis","volume":"92","author":"Purkayastha","year":"2006","journal-title":"Heart"},{"key":"2025110203540495200_ezx314-B46","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.athoracsur.2012.07.086","article-title":"2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations","volume":"94","author":"Ferraris","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2025110203540495200_ezx314-B47","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","author":"Valgimigli","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"2025110203540495200_ezx314-B49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pharmthera.2016.01.004","article-title":"Current status of data on cangrelor","volume":"159","author":"Qamar","year":"2016","journal-title":"Pharmacol Ther"},{"key":"2025110203540495200_ezx314-B50","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/eurheartj\/ehp296","article-title":"P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use","volume":"30","author":"Wallentin","year":"2009","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B51","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jamacardio.2016.3028","article-title":"Safety of preoperative use of ticagrelor with or without aspirin compared with aspirin alone in patients with acute coronary syndromes undergoing coronary artery bypass grafting","volume":"1","author":"Gherli","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2025110203540495200_ezx314-B52","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B53","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1538-7836.2011.04419.x","article-title":"Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses","volume":"9","author":"Storey","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2025110203540495200_ezx314-B54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/bja\/aew189","article-title":"Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study","volume":"117","author":"Malm","year":"2016","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B55","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/eurheartj\/ehv104","article-title":"Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention","volume":"36","author":"Aradi","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B56","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B57","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(16)31323-X","article-title":"Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial","volume":"388","author":"Cayla","year":"2016","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B58","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jacc.2010.03.108","article-title":"Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery","volume":"56","author":"Kwak","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203540495200_ezx314-B59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.athoracsur.2010.09.022","article-title":"Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines","volume":"91","author":"Ranucci","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"2025110203540495200_ezx314-B60","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/bja\/aeu315","article-title":"Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery","volume":"113","author":"Ranucci","year":"2014","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B61","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.athoracsur.2016.05.003","article-title":"Does platelet reactivity predict bleeding in patients needing urgent coronary artery bypass grafting during dual antiplatelet therapy?","volume":"102","author":"Mahla","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"2025110203540495200_ezx314-B62","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCINTERVENTIONS.111.967208","article-title":"Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study","volume":"5","author":"Mahla","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203540495200_ezx314-B63","doi-asserted-by":"crossref","first-page":"112.","DOI":"10.1186\/s12893-015-0096-z","article-title":"Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials","volume":"15","author":"Verma","year":"2015","journal-title":"BMC Surg"},{"key":"2025110203540495200_ezx314-B64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jocs.12074","article-title":"Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis","volume":"28","author":"Deo","year":"2013","journal-title":"J Card Surg"},{"key":"2025110203540495200_ezx314-B65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2016.10.043","article-title":"Dual antiplatelet therapy versus aspirin monotherapy in diabetics with multivessel disease undergoing CABG: FREEDOM insights","volume":"69","author":"van Diepen","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025110203540495200_ezx314-B66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/bja\/aep373","article-title":"Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of \u2018bridging\u2019 antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel","volume":"104","author":"Savonitto","year":"2010","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B67","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1378\/chest.126.3_suppl.234S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Patrono","year":"2004","journal-title":"Chest"},{"key":"2025110203540495200_ezx314-B68","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0003-4975(00)01343-6","article-title":"Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve long-term outcome with abciximab GP IIb\/IIIa blockade. Evaluation of platelet IIb\/IIIa inhibition in STENTing","volume":"70","author":"Lincoff","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"2025110203540495200_ezx314-B69","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijcard.2007.02.005","article-title":"Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb\/IIIa receptor inhibitors","volume":"123","author":"De Carlo","year":"2008","journal-title":"Int J Cardiol"},{"key":"2025110203540495200_ezx314-B70","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation","volume":"368","author":"Birnie","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B71","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"key":"2025110203540495200_ezx314-B72","doi-asserted-by":"crossref","first-page":"203.","DOI":"10.1186\/s13054-015-0930-9","article-title":"Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants","volume":"19","author":"Faraoni","year":"2015","journal-title":"Crit Care"},{"key":"2025110203540495200_ezx314-B73","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B74","first-page":"I19","article-title":"Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome: clinical investigation and reports","volume":"106(12 Suppl 1)","author":"Jones","year":"2002","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B75","doi-asserted-by":"crossref","first-page":"118.","DOI":"10.1016\/j.healun.2013.07.015","article-title":"Fondaparinux: an effective bridging strategy in heparin-induced thrombocytopenia and mechanical circulatory support","volume":"33","author":"Gellatly","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"2025110203540495200_ezx314-B76","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-146-3-200702060-00007","article-title":"Brief communication: preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin","volume":"146","author":"O\u2019Donnell","year":"2007","journal-title":"Ann Intern Med"},{"key":"2025110203540495200_ezx314-B77","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology","volume":"30","author":"Kozek-Langenecker","year":"2013","journal-title":"Eur J Anaesthesiol"},{"key":"2025110203540495200_ezx314-B78","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.acvd.2013.04.009","article-title":"Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP)\u2014March 2013","volume":"106","author":"Pernod","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"2025110203540495200_ezx314-B79","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jcin.2014.06.014","article-title":"Direct oral anticoagulants: new drugs and new concepts","volume":"7","author":"Levy","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203540495200_ezx314-B80","first-page":"189","article-title":"Reversing the new oral anticoagulants with prothrombin complex concentrates (PCCs): what is the evidence?","volume":"111","author":"Dickneite","year":"2013","journal-title":"Thromb Haemost"},{"key":"2025110203540495200_ezx314-B81","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"Pollack","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B82","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","article-title":"Andexanet alfa for acute major bleeding associated with factor Xa inhibitors","volume":"375","author":"Connolly","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B83","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa1510991","article-title":"Andexanet alfa for the reversal of factor Xa inhibitor activity","volume":"373","author":"Siegal","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B84","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.amjcard.2008.05.042","article-title":"Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry)","volume":"102","author":"Spyropoulos","year":"2008","journal-title":"Am J Cardiol"},{"key":"2025110203540495200_ezx314-B85","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","article-title":"Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen","volume":"164","author":"Douketis","year":"2004","journal-title":"Arch Intern Med"},{"key":"2025110203540495200_ezx314-B86","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1538-7836.2006.01908.x","article-title":"Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry","volume":"4","author":"Spyropoulos","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2025110203540495200_ezx314-B87","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/01.CIR.0000142859.77578.C9","article-title":"Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin","volume":"110","author":"Kovacs","year":"2004","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B88","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archinte.167.2.117","article-title":"Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials","volume":"167","author":"Dentali","year":"2007","journal-title":"Arch Intern Med"},{"key":"2025110203540495200_ezx314-B89","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B90","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/01.CIR.72.5.1059","article-title":"Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial","volume":"72","author":"Mok","year":"1985","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B91","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejcts\/ezs455","article-title":"Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Vahanian","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B92","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/heart.89.5.527","article-title":"Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol","volume":"89","author":"Ferreira","year":"2003","journal-title":"Heart"},{"key":"2025110203540495200_ezx314-B93","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCULATIONAHA.105.575571","article-title":"Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement","volume":"113","author":"Meurin","year":"2006","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B94","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1093\/eurheartj\/ehu365","article-title":"The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties","volume":"35","author":"Iung","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B95","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/heartjnl-2016-309585","article-title":"Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis","volume":"103","author":"Grzymala-Lubanski","year":"2017","journal-title":"Heart"},{"key":"2025110203540495200_ezx314-B96","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0140-6736(11)61294-4","article-title":"Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data","volume":"379","author":"Heneghan","year":"2012","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B97","first-page":"CD003839","article-title":"Self-monitoring and self-management of oral anticoagulation","volume":"7","author":"Heneghan","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203540495200_ezx314-B98","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehx141","article-title":"Mechanical versus bioprosthetic aortic valve replacement","author":"Head","year":"2017","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B99","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B100","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med"},{"key":"2025110203540495200_ezx314-B101","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jacc.2012.05.029","article-title":"Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database","volume":"60","author":"Brennan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203540495200_ezx314-B102","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1001\/jama.2012.54506","article-title":"Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding","volume":"308","author":"Merie","year":"2012","journal-title":"JAMA"},{"key":"2025110203540495200_ezx314-B103","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.thromres.2016.11.021","article-title":"Antithrombotic therapy after bioprosthetic aortic valve implantation: warfarin versus aspirin, a randomized controlled trial","volume":"150","author":"Rafiq","year":"2017","journal-title":"Thromb Res"},{"key":"2025110203540495200_ezx314-B104","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1161\/CIRCULATIONAHA.112.110981","article-title":"Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation","volume":"126","author":"Nombela-Franco","year":"2012","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B105","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1509233","article-title":"Possible subclinical leaflet thrombosis in bioprosthetic aortic valves","volume":"373","author":"Makkar","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B106","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.jcin.2016.06.025","article-title":"Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement","volume":"9","author":"Abdul-Jawad Altisent","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203540495200_ezx314-B107","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/clc.22230","article-title":"Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry","volume":"37","author":"Steinberg","year":"2014","journal-title":"Clin Cardiol"},{"key":"2025110203540495200_ezx314-B108","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.108.777789","article-title":"Atrial fibrillation after isolated coronary surgery affects late survival","volume":"118","author":"Mariscalco","year":"2008","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B109","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ejcts.2009.12.033","article-title":"Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality","volume":"37","author":"Ahlsson","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B110","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ejcts.2006.09.003","article-title":"Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery","volume":"30","author":"Dunning","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B111","first-page":"CD003611","article-title":"Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery","volume":"1","author":"Arsenault","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203540495200_ezx314-B112","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/bja\/aeq007","article-title":"Recommendations on perioperative beta-blockers: differing guidelines: so what should the clinician do?","volume":"104","author":"Sear","year":"2010","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B113","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/pace.12140","article-title":"Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis","volume":"36","author":"Chatterjee","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203540495200_ezx314-B114","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/europace\/eup429","article-title":"Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?","volume":"12","author":"Heidarsdottir","year":"2010","journal-title":"Europace"},{"key":"2025110203540495200_ezx314-B115","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.jacc.2005.02.079","article-title":"N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial","volume":"45","author":"Calo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2025110203540495200_ezx314-B116","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/hrt.2004.033811","article-title":"Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis","volume":"91","author":"Miller","year":"2005","journal-title":"Heart"},{"key":"2025110203540495200_ezx314-B117","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/14017431.2012.740572","article-title":"Pharmacological conversion of recent-onset atrial fibrillation: a systematic review","volume":"47","author":"Heldal","year":"2013","journal-title":"Scand Cardiovasc J Suppl"},{"key":"2025110203540495200_ezx314-B118","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCEP.109.870204","article-title":"Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial","volume":"2","author":"Kowey","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025110203540495200_ezx314-B119","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate control versus rhythm control for atrial fibrillation after cardiac surgery","volume":"374","author":"Gillinov","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B120","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/eurheartj\/ehv143","article-title":"Digoxin-associated mortality: a systematic review and meta-analysis of the literature","volume":"36","author":"Vamos","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B121","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jama.2014.9143","article-title":"Perioperative atrial fibrillation and the long-term risk of ischemic stroke","volume":"312","author":"Gialdini","year":"2014","journal-title":"JAMA"},{"key":"2025110203540495200_ezx314-B122","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cll.2014.06.012","article-title":"Anticoagulation strategies for the management of postoperative atrial fibrillation","volume":"34","author":"Anderson","year":"2014","journal-title":"Clin Lab Med"},{"key":"2025110203540495200_ezx314-B123","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B124","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcin.2016.10.023","article-title":"Apixaban in patients with atrial fibrillation after transfemoral aortic valve replacement","volume":"10","author":"Seeger","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203540495200_ezx314-B125","first-page":"CD004476","article-title":"Perioperative beta-blockers for preventing surgery-related mortality and morbidity","volume":"9","author":"Blessberger","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203540495200_ezx314-B126","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/jamainternmed.2014.2356","article-title":"Preoperative beta-blocker use in coronary artery bypass grafting surgery: national database analysis","volume":"174","author":"Brinkman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025110203540495200_ezx314-B127","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1067\/mhj.2003.147","article-title":"Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study","volume":"145","author":"Connolly","year":"2003","journal-title":"Am Heart J"},{"key":"2025110203540495200_ezx314-B128","doi-asserted-by":"crossref","first-page":"II200","DOI":"10.1161\/01.cir.0000087445.59819.6f","article-title":"Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II)","volume":"108","author":"White","year":"2003","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B129","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1001\/jama.294.24.3093","article-title":"Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial","volume":"294","author":"Mitchell","year":"2005","journal-title":"JAMA"},{"key":"2025110203540495200_ezx314-B130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1023\/A:1027428003609","article-title":"Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results","volume":"7","author":"Lee","year":"2003","journal-title":"Card Electrophysiol Rev"},{"key":"2025110203540495200_ezx314-B131","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1023\/A:1027439430017","article-title":"The RACE study in perspective of randomized studies on management of persistent atrial fibrillation","volume":"7","author":"Hagens","year":"2003","journal-title":"Card Electrophysiol Rev"},{"key":"2025110203540495200_ezx314-B132","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B133","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ahj.2009.09.003","article-title":"Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial","volume":"158","author":"Al-Khatib","year":"2009","journal-title":"Am Heart J"},{"key":"2025110203540495200_ezx314-B134","doi-asserted-by":"crossref","first-page":"603.e1","DOI":"10.1016\/j.amjmed.2011.09.030","article-title":"Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation","volume":"125","author":"Mason","year":"2012","journal-title":"Am J Med"},{"key":"2025110203540495200_ezx314-B135","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B136","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/j.jvca.2016.04.003","article-title":"Pro: ACE inhibitors should be continued perioperatively and prior to cardiovascular operations","volume":"30","author":"Bhatia","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B137","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/j.jvca.2016.01.016","article-title":"Con: ACE inhibitors should be stopped prior to cardiovascular surgery","volume":"30","author":"Disque","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B138","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jcrc.2015.02.017","article-title":"Renin-angiotensin system blockers in cardiac surgery","volume":"30","author":"Mangieri","year":"2015","journal-title":"J Crit Care"},{"key":"2025110203540495200_ezx314-B139","first-page":"CD009210","article-title":"Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults","volume":"1","author":"Zou","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203540495200_ezx314-B140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000539-200101000-00006","article-title":"Should the angiotensin II antagonists be discontinued before surgery?","volume":"92","author":"Bertrand","year":"2001","journal-title":"Anesth Analg"},{"key":"2025110203540495200_ezx314-B141","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.106.685073","article-title":"Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery","volume":"117","author":"Rouleau","year":"2008","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B142","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ejcts\/ezu298","article-title":"Effect of preoperative angiotensin-converting enzyme inhibitor on the outcome of coronary artery bypass graft surgery","volume":"47","author":"Zhang","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B143","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-5223(98)70049-2","article-title":"Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent","volume":"116","author":"Argenziano","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B144","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1540-8191.2000.tb00470.x","article-title":"Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance","volume":"15","author":"Carrel","year":"2000","journal-title":"J Card Surg"},{"key":"2025110203540495200_ezx314-B145","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"2025110203540495200_ezx314-B146","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/HJH.0000000000000221","article-title":"European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring","volume":"32","author":"Parati","year":"2014","journal-title":"J Hypertens"},{"key":"2025110203540495200_ezx314-B147","first-page":"CD003611","article-title":"Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery","volume":"4","author":"Crystal","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203540495200_ezx314-B148","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B149","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B150","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B151","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0002-9149(00)01428-4","article-title":"Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia","volume":"87","author":"Oosterga","year":"2001","journal-title":"Am J Cardiol"},{"key":"2025110203540495200_ezx314-B152","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2215\/CJN.05271107","article-title":"Preoperative use of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery","volume":"3","author":"Arora","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025110203540495200_ezx314-B153","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jacc.2012.10.011","article-title":"A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure","volume":"61","author":"Savarese","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203540495200_ezx314-B154","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B156","doi-asserted-by":"crossref","first-page":"1090.e1","DOI":"10.1016\/j.amjmed.2007.02.029","article-title":"Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy","volume":"120","author":"Jneid","year":"2007","journal-title":"Am J Med"},{"key":"2025110203540495200_ezx314-B157","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ehjcvp\/pvw016","article-title":"Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives","volume":"3","author":"Pitt","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025110203540495200_ezx314-B158","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B159","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B160","first-page":"1429","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B161","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B162","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jtcvs.2010.03.015","article-title":"Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery","volume":"140","author":"Chan","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B163","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/bja\/aeg013","article-title":"Effect of preoperative beta-blockade on perioperative mortality in coronary surgery","volume":"90","author":"ten Broecke","year":"2003","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B164","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/ACO.0b013e3282f35ea5","article-title":"Perioperative beta-blocker and statin therapy","volume":"21","author":"Daumerie","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"key":"2025110203540495200_ezx314-B165","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1001\/jama.2015.1883","article-title":"Perioperative use of beta-blockers in cardiac and noncardiac surgery","volume":"313","author":"Blessberger","year":"2015","journal-title":"JAMA"},{"key":"2025110203540495200_ezx314-B166","first-page":"Doc12","article-title":"S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculary system","volume":"8","author":"Carl","year":"2010","journal-title":"Ger Med Sci"},{"key":"2025110203540495200_ezx314-B167","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/hrt.74.3.235","article-title":"Metoprolol treatment for two years after coronary bypass grafting: effects on exercise capacity and signs of myocardial ischaemia","volume":"74","author":"Sjoland","year":"1995","journal-title":"Br Heart J"},{"key":"2025110203540495200_ezx314-B168","doi-asserted-by":"crossref","first-page":"i4801","DOI":"10.1136\/bmj.i4801","article-title":"\u03b2 blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study","volume":"354","author":"Puymirat","year":"2016","journal-title":"Br Med J"},{"key":"2025110203540495200_ezx314-B169","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10557-015-6600-y","article-title":"\u03b2-blocker therapy is not associated with reductions in angina or cardiovascular events after coronary artery bypass graft surgery: insights from the IMAGINE Trial","volume":"29","author":"Booij","year":"2015","journal-title":"Cardiovasc Drugs Ther"},{"key":"2025110203540495200_ezx314-B170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1751-7133.2010.00146.x","article-title":"Mortality reduction with beta-blockers in ischemic cardiomyopathy patients undergoing coronary artery bypass grafting","volume":"16","author":"Lin","year":"2010","journal-title":"Congest Heart Fail"},{"key":"2025110203540495200_ezx314-B171","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B172","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7326\/0003-4819-134-7-200104030-00008","article-title":"Beta-blockers in congestive heart failure. A Bayesian meta-analysis","volume":"134","author":"Brophy","year":"2001","journal-title":"Ann Intern Med"},{"key":"2025110203540495200_ezx314-B173","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B174","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B175","doi-asserted-by":"crossref","first-page":"f55","DOI":"10.1136\/bmj.f55","article-title":"Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: network meta-analysis","volume":"346","author":"Chatterjee","year":"2013","journal-title":"Br Med J"},{"key":"2025110203540495200_ezx314-B176","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.287.17.2221","article-title":"Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America","volume":"287","author":"Ferguson","year":"2002","journal-title":"JAMA"},{"key":"2025110203540495200_ezx314-B177","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jtcvs.2008.06.038","article-title":"Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial","volume":"136","author":"Mannacio","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B178","first-page":"CD008493","article-title":"Preoperative statin therapy for patients undergoing cardiac surgery","volume":"8","author":"Kuhn","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203540495200_ezx314-B179","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMoa1507750","article-title":"Perioperative rosuvastatin in cardiac surgery","volume":"374","author":"Zheng","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B180","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.2016.0548","article-title":"High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery. A randomized clinical trial","volume":"315","author":"Billings","year":"2016","journal-title":"JAMA"},{"key":"2025110203540495200_ezx314-B181","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/jama.2016.0245","article-title":"Perioperative statins in cardiac surgery and acute kidney injury","volume":"315","author":"Bellomo","year":"2016","journal-title":"JAMA"},{"key":"2025110203540495200_ezx314-B182","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2007.12.054","article-title":"Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery","volume":"51","author":"Shah","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2025110203540495200_ezx314-B183","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B184","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B185","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B186","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/eurheartj\/ehv563","article-title":"The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis","volume":"37","author":"Lipinski","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B187","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(10)60656-3","article-title":"Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis","volume":"375","author":"Jun","year":"2010","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B188","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"ACCORD Study Group","year":"2010","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B189","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Cholesterol Treatment Trialists\u2019 Collaboration","year":"2015","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B190","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S2213-8587(16)00003-6","article-title":"Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data","volume":"4","author":"Sattar","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025110203540495200_ezx314-B191","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/M14-2957","article-title":"Effects of proprotein convertase subtilisin\/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis","volume":"163","author":"Navarese","year":"2015","journal-title":"Ann Intern Med"},{"key":"2025110203540495200_ezx314-B192","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/SLA.0b013e3180603010","article-title":"Predictors and outcome of gastrointestinal complications in patients undergoing cardiac surgery","volume":"246","author":"Filsoufi","year":"2007","journal-title":"Ann Surg"},{"key":"2025110203540495200_ezx314-B193","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/cr.2000.5849","article-title":"Pathogenesis, risk factors, and incidence of upper gastrointestinal bleeding after cardiac surgery: is specific prophylaxis in routine bypass procedures needed?","volume":"14","author":"van der Voort","year":"2000","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B194","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/icvts\/ivs019","article-title":"Is routine stress ulcer prophylaxis of benefit for patients undergoing cardiac surgery?","volume":"14","author":"Shin","year":"2012","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203540495200_ezx314-B195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1253\/circj.69.331","article-title":"Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery","volume":"69","author":"Hata","year":"2005","journal-title":"Circ J"},{"key":"2025110203540495200_ezx314-B196","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1503\/cmaj.092129","article-title":"Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis","volume":"183","author":"Eom","year":"2011","journal-title":"CMAJ"},{"key":"2025110203540495200_ezx314-B197","first-page":"355:i5813","article-title":"Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study","author":"Othman","year":"2016","journal-title":"Br Med J"},{"key":"2025110203540495200_ezx314-B198","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/icvts\/ivs483","article-title":"What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?","volume":"16","author":"Patel","year":"2013","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203540495200_ezx314-B199","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijsu.2005.04.002","article-title":"The systemic inflammatory response syndrome and cardiopulmonary bypass","volume":"3","author":"Day","year":"2005","journal-title":"Int J Surg"},{"key":"2025110203540495200_ezx314-B200","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/eurheartj\/ehn333","article-title":"Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials","volume":"29","author":"Whitlock","year":"2008","journal-title":"Eur Heart J"},{"key":"2025110203540495200_ezx314-B201","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(15)00273-1","article-title":"Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Whitlock","year":"2015","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B202","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1001\/jama.2012.14144","article-title":"Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial","volume":"308","author":"Dieleman","year":"2012","journal-title":"JAMA"},{"key":"2025110203540495200_ezx314-B203","first-page":"6","article-title":"Corticosteroids for cardiac surgery: a summary of two large randomised trials","volume":"24","author":"Dieleman","year":"2016","journal-title":"Neth J Crit Care"},{"key":"2025110203540495200_ezx314-B204","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ALN.0000000000001659","article-title":"Perioperative steroid management: approaches based on current evidence","volume":"127","author":"Liu","year":"2017","journal-title":"Anesthesiology"},{"key":"2025110203540495200_ezx314-B205","first-page":"I358","article-title":"Clinical predictors of major infections after cardiac surgery","volume":"112(9 suppl)","author":"Fowler","year":"2005","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B206","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jacc.2014.04.052","article-title":"Management practices and major infections after cardiac surgery","volume":"64","author":"Gelijns","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203540495200_ezx314-B207","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jtcvs.2015.01.034","article-title":"Gentamicin-collagen sponge reduces the risk of sternal wound infections after heart surgery: meta-analysis","volume":"149","author":"Kowalewski","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B208","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1128\/AAC.46.9.3026-3030.2002","article-title":"Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy","volume":"46","author":"Zelenitsky","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2025110203540495200_ezx314-B209","first-page":"750","article-title":"Antibiotic prophylaxis for surgery in morbidly obese patients","volume":"106","author":"Forse","year":"1989","journal-title":"Surgery"},{"key":"2025110203540495200_ezx314-B210","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(09)60743-1","article-title":"Adjustment of dosing of antimicrobial agents for bodyweight in adults","volume":"375","author":"Falagas","year":"2010","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B211","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1592\/phco.27.8.1081","article-title":"Antimicrobial dosing considerations in obese adult patients","volume":"27","author":"Pai","year":"2007","journal-title":"Pharmacotherapy"},{"key":"2025110203540495200_ezx314-B212","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jtcvs.2008.05.013","article-title":"Comparative study of single-dose and 24-hour multiple-dose antibiotic prophylaxis for cardiac surgery","volume":"136","author":"Tamayo","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B213","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/SLA.0b013e318214b7e4","article-title":"Does duration of perioperative antibiotic prophylaxis matter in cardiac surgery? A systematic review and meta-analysis","volume":"254","author":"Mertz","year":"2011","journal-title":"Ann Surg"},{"key":"2025110203540495200_ezx314-B214","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1161\/01.CIR.101.25.2916","article-title":"Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance","volume":"101","author":"Harbarth","year":"2000","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B215","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archsurg.140.2.174","article-title":"Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project","volume":"140","author":"Bratzler","year":"2005","journal-title":"Arch Surg"},{"key":"2025110203540495200_ezx314-B216","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/jac\/dkg442","article-title":"Effect of extended perioperative antibiotic prophylaxis on intravascular catheter colonization and infection in cardiothoracic surgery patients","volume":"52","author":"Sandoe","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2025110203540495200_ezx314-B217","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-5223(97)70140-5","article-title":"Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective?","volume":"114","author":"Niederhauser","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B218","doi-asserted-by":"crossref","first-page":"943","DOI":"10.7326\/0003-4819-76-6-943","article-title":"Antibiotic prophylaxis and cardiac surgery. A prospective double-blind comparison of single-dose versus multiple-dose regimens","volume":"76","author":"Conte","year":"1972","journal-title":"Ann Intern Med"},{"key":"2025110203540495200_ezx314-B219","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.jvca.2015.03.026","article-title":"Continuous intraoperative cefazolin infusion may reduce surgical site infections during cardiac surgical procedures: a propensity-matched analysis","volume":"29","author":"Trent Magruder","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B220","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1086\/421095","article-title":"Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project","volume":"38","author":"Bratzler","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2025110203540495200_ezx314-B221","first-page":"59","article-title":"Studies on the duration of antibiotic administration for surgical prophylaxis","volume":"63","author":"Scher","year":"1997","journal-title":"Am Surg"},{"key":"2025110203540495200_ezx314-B222","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archsurg.1996.01430230047009","article-title":"Does intraoperative blood loss affect antibiotic serum and tissue concentrations?","volume":"131","author":"Swoboda","year":"1996","journal-title":"Arch Surg"},{"key":"2025110203540495200_ezx314-B223","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jtcvs.2016.04.024","article-title":"Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery","volume":"152","author":"Lanckohr","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B224","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1010-7940(02)00084-2","article-title":"Postoperative mediastinitis in cardiac surgery\u2014microbiology and pathogenesis","volume":"21","author":"Gardlund","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B225","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/14017431.2016.1180427","article-title":"Sternal wound infections following open heart surgery\u2014a review","volume":"50","author":"Gudbjartsson","year":"2016","journal-title":"Scand Cardiovasc J"},{"key":"2025110203540495200_ezx314-B226","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1016\/S1473-3099(16)30398-X","article-title":"New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective","volume":"16","author":"Allegranzi","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2025110203540495200_ezx314-B227","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa0808939","article-title":"Preventing surgical-site infections in nasal carriers of Staphylococcus aureus","volume":"362","author":"Bode","year":"2010","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B228","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/14017439409099119","article-title":"Ceftriaxone vs cefuroxime for infection prophylaxis in coronary bypass surgery","volume":"28","author":"Sisto","year":"1994","journal-title":"Scand J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B229","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/BF02111823","article-title":"Prospective randomised comparison of single-dose versus multiple-dose cefuroxime for prophylaxis in coronary artery bypass grafting","volume":"13","author":"Nooyen","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025110203540495200_ezx314-B230","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1010-7940(00)00469-3","article-title":"Evolution of antimicrobial prophylaxis in cardiovascular surgery","volume":"18","author":"Kriaras","year":"2000","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B231","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/jac\/dkr470","article-title":"Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis","volume":"67","author":"Lador","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2025110203540495200_ezx314-B232","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1086\/383318","article-title":"Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis","volume":"38","author":"Bolon","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2025110203540495200_ezx314-B233","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.mcna.2006.07.005","article-title":"Antibiotic selection in the penicillin-allergic patient","volume":"90","author":"Cunha","year":"2006","journal-title":"Med Clin North Am"},{"key":"2025110203540495200_ezx314-B234","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1128\/AAC.36.11.2539","article-title":"Penetration of vancomycin in uninfected sternal bone","volume":"36","author":"Massias","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"2025110203540495200_ezx314-B235","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1067\/mtc.2002.119698","article-title":"Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections","volume":"123","author":"Finkelstein","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B236","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.anai.2015.05.011","article-title":"Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy","volume":"115","author":"Blumenthal","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025110203540495200_ezx314-B237","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2025110203540495200_ezx314-B238","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0025-6196(11)60893-8","article-title":"Preoperative evaluation of patients with history of allergy to penicillin: comparison of 2 models of practice","volume":"83","author":"Frigas","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"2025110203540495200_ezx314-B239","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1086\/676022","article-title":"Strategies to prevent surgical site infections in Acute Care Hospitals: 2014 update","volume":"35","author":"Anderson","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025110203540495200_ezx314-B240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.jvca.2004.12.002","article-title":"Methicillin-resistant Staphylococcus species in a cardiac surgical intensive care unit: a 5-year experience","volume":"20","author":"Zangrillo","year":"2006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B241","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/SLA.0b013e31825fa398","article-title":"Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive Staphylococcus aureus surgical site infections: report from Australian Surveillance Data (VICNISS)","volume":"256","author":"Bull","year":"2012","journal-title":"Ann Surg"},{"key":"2025110203540495200_ezx314-B242","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199201303260501","article-title":"The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection","volume":"326","author":"Classen","year":"1992","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B243","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/SLA.0b013e3181ad5fca","article-title":"Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors","volume":"250","author":"Steinberg","year":"2009","journal-title":"Ann Surg"},{"key":"2025110203540495200_ezx314-B244","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1086\/512192","article-title":"Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor","volume":"44","author":"van Kasteren","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2025110203540495200_ezx314-B245","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/SLA.0b013e31816c3fec","article-title":"The timing of surgical antimicrobial prophylaxis","volume":"247","author":"Weber","year":"2008","journal-title":"Ann Surg"},{"key":"2025110203540495200_ezx314-B246","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jac\/dkl279","article-title":"Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections","volume":"58","author":"Garey","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2025110203540495200_ezx314-B247","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0022-5223(19)34723-3","article-title":"Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials","volume":"104","author":"Kreter","year":"1992","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B248","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0195-6701(97)90252-8","article-title":"Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels","volume":"37","author":"Vuorisalo","year":"1997","journal-title":"J Hosp Infect"},{"key":"2025110203540495200_ezx314-B249","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jfma.2011.08.003","article-title":"Prospective randomized study of efficacy of 1-day versus 3-day antibiotic prophylaxis for preventing surgical site infection after coronary artery bypass graft","volume":"110","author":"Lin","year":"2011","journal-title":"J Formos Med Assoc"},{"key":"2025110203540495200_ezx314-B250","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/jac\/dkq080","article-title":"Comparison of 48\u2009h and 72\u2009h of prophylactic antibiotic therapy in adult cardiac surgery: a randomized double blind controlled trial","volume":"65","author":"Gupta","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2025110203540495200_ezx314-B251","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3201\/eid0705.017509","article-title":"Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery","volume":"7","author":"Zanetti","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"2025110203540495200_ezx314-B252","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/jinf.2002.1032","article-title":"Vancomycin sequestration during cardiopulmonary bypass surgery","volume":"45","author":"Krivoy","year":"2002","journal-title":"J Infect"},{"key":"2025110203540495200_ezx314-B253","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0003-4975(02)03916-4","article-title":"Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery","volume":"74","author":"Fellinger","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"2025110203540495200_ezx314-B254","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1510\/icvts.2006.147769","article-title":"Cefuroxime as antibiotic prophylaxis in coronary artery bypass grafting surgery","volume":"6","author":"Mastoraki","year":"2007","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203540495200_ezx314-B255","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"2025110203540495200_ezx314-B256","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/ALN.0000000000001120","article-title":"Effects of volatile anesthetics on mortality and postoperative pulmonary and other complications in patients undergoing surgery: a systematic review and meta-analysis","volume":"124","author":"Uhlig","year":"2016","journal-title":"Anesthesiology"},{"key":"2025110203540495200_ezx314-B257","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/bja\/aet231","article-title":"Anaesthetic drugs and survival: a Bayesian network meta-analysis of randomized trials in cardiac surgery","volume":"111","author":"Landoni","year":"2013","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B258","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/bja\/aev201","article-title":"Benefits and risks of epidural analgesia in cardiac surgery","volume":"115","author":"Landoni","year":"2015","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B259","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.jvca.2012.06.007","article-title":"The effect of isoflurane on survival and myocardial infarction: a meta-analysis of randomized controlled studies","volume":"27","author":"Bignami","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B260","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/j.jvca.2009.01.022","article-title":"Volatile anesthetics reduce mortality in cardiac surgery","volume":"23","author":"Bignami","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B261","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2044.2009.06008.x","article-title":"A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery","volume":"64","author":"De Hert","year":"2009","journal-title":"Anaesthesia"},{"key":"2025110203540495200_ezx314-B262","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.jvca.2007.03.002","article-title":"The influence of propofol versus sevoflurane anesthesia on outcome in 10, 535 cardiac surgical procedures","volume":"21","author":"Jakobsen","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B263","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.jvca.2007.02.013","article-title":"Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials","volume":"21","author":"Landoni","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B264","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1053\/j.jvca.2016.02.030","article-title":"Sevoflurane versus total intravenous anesthesia for isolated coronary artery bypass surgery with cardiopulmonary bypass: a randomized trial","volume":"30","author":"Likhvantsev","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B265","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1053\/j.jvca.2011.08.001","article-title":"Poststernotomy pain: a clinical review","volume":"25","author":"Mazzeffi","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B266","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.iccn.2007.03.002","article-title":"Management of pain in cardiac surgery ICU patients: have we improved over time?","volume":"23","author":"Gelinas","year":"2007","journal-title":"Intensive Crit Care Nurs"},{"key":"2025110203540495200_ezx314-B267","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/01.CCM.0000069512.10544.40","article-title":"Exposure to high stress in the intensive care unit may have negative effects on health-related quality-of-life outcomes after cardiac surgery","volume":"31","author":"Schelling","year":"2003","journal-title":"Crit Care Med"},{"key":"2025110203540495200_ezx314-B268","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","article-title":"Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit","volume":"41","author":"Barr","year":"2013","journal-title":"Crit Care Med"},{"key":"2025110203540495200_ezx314-B269","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","article-title":"Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists\u2019 Committee on Regional Anesthesia, Executive Committee, and Administrative Council","volume":"17","author":"Chou","year":"2016","journal-title":"J Pain"},{"key":"2025110203540495200_ezx314-B270","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1053\/j.jvca.2009.07.002","article-title":"Spinal analgesia in cardiac surgery: a meta-analysis of randomized controlled trials","volume":"23","author":"Zangrillo","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B271","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/AJP.0b013e3181817add","article-title":"Adjuvant therapy with intrathecal clonidine improves postoperative pain in patients undergoing coronary artery bypass graft","volume":"25","author":"Nader","year":"2009","journal-title":"Clin J Pain"},{"key":"2025110203540495200_ezx314-B272","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.jvca.2004.11.009","article-title":"Fast-track coronary artery bypass grafting surgery under general anesthesia with remifentanil and spinal analgesia with morphine and clonidine","volume":"19","author":"Lena","year":"2005","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B273","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00000542-200310000-00026","article-title":"Use of a continuous local anesthetic infusion for pain management after median sternotomy","volume":"99","author":"White","year":"2003","journal-title":"Anesthesiology"},{"key":"2025110203540495200_ezx314-B274","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1213\/01.ANE.0000139652.84897.BD","article-title":"Parasternal block and local anesthetic infiltration with levobupivacaine after cardiac surgery with desflurane: the effect on postoperative pain, pulmonary function, and tracheal extubation times","volume":"100","author":"McDonald","year":"2005","journal-title":"Anesth Analg"},{"key":"2025110203540495200_ezx314-B275","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/bja\/aen360","article-title":"Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists","volume":"102","author":"Cook","year":"2009","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B276","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1510\/icvts.2008.190686","article-title":"Is intrathecal morphine of benefit to patients undergoing cardiac surgery","volume":"8","author":"Richardson","year":"2009","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203540495200_ezx314-B277","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/bja\/aes344","article-title":"Efficacy of adding clonidine to intrathecal morphine in acute postoperative pain: meta-analysis","volume":"110","author":"Engelman","year":"2013","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B278","first-page":"CD009121","article-title":"Paravertebral block versus thoracic epidural for patients undergoing thoracotomy","volume":"2","author":"Yeung","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203540495200_ezx314-B279","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2044.2003.03082_2.x","article-title":"Bilateral paravertebral blockade for conventional cardiac surgery","volume":"58","author":"Canto","year":"2003","journal-title":"Anaesthesia"},{"key":"2025110203540495200_ezx314-B280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0971-9784.148314","article-title":"The analgesic efficacy of continuous presternal bupivacaine infusion through a single catheter after cardiac surgery","volume":"18","author":"Nasr","year":"2015","journal-title":"Ann Card Anaesth"},{"key":"2025110203540495200_ezx314-B281","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/AAP.0b013e318281a348","article-title":"A prospective, randomized, blinded study of continuous ropivacaine infusion in the median sternotomy incision following cardiac surgery","volume":"38","author":"Agarwal","year":"2013","journal-title":"Reg Anesth Pain Med"},{"key":"2025110203540495200_ezx314-B282","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1017\/S0265021508004614","article-title":"Infiltration of the sternotomy wound and the mediastinal tube sites with 0.25% levobupivacaine as adjunctive treatment for postoperative pain after cardiac surgery","volume":"25","author":"Kocabas","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"2025110203540495200_ezx314-B283","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF03022623","article-title":"Patient-controlled versus nurse-controlled analgesia after cardiac surgery\u2013a meta-analysis","volume":"53","author":"Bainbridge","year":"2006","journal-title":"Can J Anaesth"},{"key":"2025110203540495200_ezx314-B284","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.jvca.2011.05.007","article-title":"Remifentanil in cardiac surgery: a meta-analysis of randomized controlled trials","volume":"26","author":"Greco","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B285","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0218492313507783","article-title":"Patient-controlled analgesia after coronary bypass: remifentanil or sufentanil?","volume":"22","author":"Alavi","year":"2014","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"2025110203540495200_ezx314-B286","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/j.jvca.2008.07.006","article-title":"The efficacy of intravenous patient-controlled remifentanil versus morphine anesthesia after coronary artery surgery","volume":"23","author":"Baltali","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B287","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jtcvs.2016.04.078","article-title":"Intravenous acetaminophen analgesia after cardiac surgery: a randomized, blinded, controlled superiority trial","volume":"152","author":"Mamoun","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B288","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/j.jvca.2016.02.010","article-title":"Intravenous acetaminophen as an adjunct analgesic in cardiac surgery reduces opioid consumption but not opioid-related adverse effects: a randomized controlled trial","volume":"30","author":"Jelacic","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B289","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejcts.2007.05.017","article-title":"Intravenous paracetamol as adjunctive treatment for postoperative pain after cardiac surgery: a double blind randomized controlled trial","volume":"32","author":"Cattabriga","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B290","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/0310057X1103900612","article-title":"Aminotransferase levels in relation to short-term use of acetaminophen four grams daily in postoperative cardiothoracic patients in the intensive care unit","volume":"39","author":"Ahlers","year":"2011","journal-title":"Anaesth Intensive Care"},{"key":"2025110203540495200_ezx314-B291","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/pds.3788","article-title":"Non-steroidal anti-inflammatory drug administration after coronary artery bypass surgery: utilization persists despite the boxed warning","volume":"24","author":"Kulik","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025110203540495200_ezx314-B292","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Coxib and traditional NSAID Trialists' (CNT) Collaboration","year":"2013","journal-title":"Lancet"},{"key":"2025110203540495200_ezx314-B293","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1161\/CIRCULATIONAHA.110.004671","article-title":"Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study","volume":"123","author":"Schjerning Olsen","year":"2011","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B294","doi-asserted-by":"crossref","first-page":"141","DOI":"10.15171\/jcvtr.2015.31","article-title":"Ibuprofen\u2014a safe analgesic during cardiac surgery recovery? A randomized controlled trial","volume":"7","author":"Qazi","year":"2015","journal-title":"J Cardiovasc Thorac Res"},{"key":"2025110203540495200_ezx314-B295","doi-asserted-by":"crossref","first-page":"52.","DOI":"10.1186\/1749-8090-9-52","article-title":"Multimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trial","volume":"9","author":"Rafiq","year":"2014","journal-title":"J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B296","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.amjmed.2011.07.026","article-title":"Naproxen as prophylaxis against atrial fibrillation after cardiac surgery: the NAFARM randomized trial","volume":"124","author":"Horbach","year":"2011","journal-title":"Am J Med"},{"key":"2025110203540495200_ezx314-B297","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1517\/17425255.2014.971010","article-title":"Competition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs\u2019 antiplatelet effects","volume":"11","author":"Stepensky","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2025110203540495200_ezx314-B298","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1510\/icvts.2010.239053","article-title":"Does the use of non-steroidal anti-inflammatory drugs after cardiac surgery increase the risk of renal failure?","volume":"11","author":"Acharya","year":"2010","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203540495200_ezx314-B299","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF03021527","article-title":"NSAID-analgesia, pain control and morbidity in cardiothoracic surgery","volume":"53","author":"Bainbridge","year":"2006","journal-title":"Can J Anaesth"},{"key":"2025110203540495200_ezx314-B300","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.jvca.2004.08.012","article-title":"Opioid-sparing effects of diclofenac and paracetamol lead to improved outcomes after cardiac surgery","volume":"18","author":"Fayaz","year":"2004","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B301","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ejcts.2004.07.004","article-title":"Postoperative naproxen after coronary artery bypass surgery: a double-blind randomized controlled trial","volume":"26","author":"Kulik","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B302","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.jvca.2013.07.014","article-title":"Black box warning: is ketorolac safe for use after cardiac surgery?","volume":"28","author":"Oliveri","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B303","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/j.jvca.2007.01.024","article-title":"Postoperative analgesia with ketorolac is associated with decreased mortality after isolated coronary artery bypass graft surgery in patients already receiving aspirin: a propensity-matched study","volume":"21","author":"Engoren","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B304","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0022-5223(03)00125-9","article-title":"Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery","volume":"125","author":"Ott","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B305","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa050330","article-title":"Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery","volume":"352","author":"Nussmeier","year":"2005","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B306","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/ejcts\/ezu032","article-title":"Perioperative gabapentin for the prevention of persistent pain after thoracotomy: a randomized controlled trial","volume":"46","author":"Grosen","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B307","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/bja\/aeu293","article-title":"Impact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysis","volume":"114","author":"Mishriky","year":"2015","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B308","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.phrs.2008.06.003","article-title":"Ketamine spares morphine consumption after transthoracic lung and heart surgery without adverse hemodynamic effects","volume":"58","author":"Nesher","year":"2008","journal-title":"Pharmacol Res"},{"key":"2025110203540495200_ezx314-B309","first-page":"49","article-title":"Spinal anesthesia reduces postoperative delirium in opium dependent patients undergoing coronary artery bypass grafting","volume":"66","author":"Tabatabaie","year":"2015","journal-title":"Acta Anaesthesiol Belg"},{"key":"2025110203540495200_ezx314-B310","doi-asserted-by":"crossref","first-page":"E205","DOI":"10.1532\/HSF98.20033014","article-title":"Spinal (subarachnoid) morphine for off-pump coronary artery bypass surgery","volume":"7","author":"Mehta","year":"2004","journal-title":"Heart Surg Forum"},{"key":"2025110203540495200_ezx314-B311","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/icvts\/ivt301","article-title":"Is there a role for gabapentin in preventing or treating pain following thoracic surgery?","volume":"17","author":"Zakkar","year":"2013","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203540495200_ezx314-B312","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1213\/01.ANE.0000133913.07342.B9","article-title":"S(+)-ketamine as an analgesic adjunct reduces opioid consumption after cardiac surgery","volume":"99","author":"Lahtinen","year":"2004","journal-title":"Anesth Analg"},{"key":"2025110203540495200_ezx314-B313","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/bja\/aen095","article-title":"Comparison of S-(+)-ketamine- with sufentanil-based anaesthesia for elective coronary artery bypass graft surgery: effect on troponin T levels","volume":"100","author":"Neuhauser","year":"2008","journal-title":"Br J Anaesth"},{"key":"2025110203540495200_ezx314-B314","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1378\/chest.08-0246","article-title":"Morphine with adjuvant ketamine vs higher dose of morphine alone for immediate postthoracotomy analgesia","volume":"136","author":"Nesher","year":"2009","journal-title":"Chest"},{"key":"2025110203540495200_ezx314-B315","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.athoracsur.2004.10.035","article-title":"Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery","volume":"79","author":"Kubal","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"2025110203540495200_ezx314-B316","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.107.706416","article-title":"Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery","volume":"118","author":"Ascione","year":"2008","journal-title":"Circulation"},{"key":"2025110203540495200_ezx314-B317","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-146-4-200702200-00002","article-title":"Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial","volume":"146","author":"Gandhi","year":"2007","journal-title":"Ann Intern Med"},{"key":"2025110203540495200_ezx314-B318","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B319","doi-asserted-by":"crossref","first-page":"3.","DOI":"10.1186\/1749-8090-6-3","article-title":"The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: a systematic review and meta-analysis","volume":"6","author":"Haga","year":"2011","journal-title":"J Cardiothorac Surg"},{"key":"2025110203540495200_ezx314-B320","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.hrtlng.2012.12.007","article-title":"Effects of intensive glycemic control on outcomes of cardiac surgery","volume":"42","author":"Giakoumidakis","year":"2013","journal-title":"Heart Lung"},{"key":"2025110203540495200_ezx314-B321","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jtcvs.2008.02.091","article-title":"Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery","volume":"136","author":"Halkos","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B322","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00134-016-4299-2","article-title":"Tight glycemic control in acutely ill patients: low evidence of benefit, high evidence of harm!","volume":"42","author":"Marik","year":"2016","journal-title":"Intensive Care Med"},{"key":"2025110203540495200_ezx314-B323","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s00134-016-4374-8","article-title":"Glycemic control: please agree to disagree","volume":"42","author":"Preiser","year":"2016","journal-title":"Intensive Care Med"},{"key":"2025110203540495200_ezx314-B324","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jtcvs.2010.10.005","article-title":"Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting","volume":"141","author":"Bhamidipati","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B325","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/SLA.0b013e31822c5d78","article-title":"Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients","volume":"254","author":"Lazar","year":"2011","journal-title":"Ann Surg"},{"key":"2025110203540495200_ezx314-B326","first-page":"CD007315","article-title":"Perioperative glycaemic control for diabetic patients undergoing surgery","volume":"9","author":"Buchleitner","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203540495200_ezx314-B327","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jtcvs.2011.10.070","article-title":"Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial","volume":"143","author":"Desai","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B328","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2337\/dc15-0303","article-title":"Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial","volume":"38","author":"Umpierrez","year":"2015","journal-title":"Diabetes Care"},{"key":"2025110203540495200_ezx314-B329","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"NICE-SUGAR Study Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203540495200_ezx314-B330","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0000000000000688","article-title":"Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes","volume":"261","author":"Kotagal","year":"2015","journal-title":"Ann Surg"},{"key":"2025110203540495200_ezx314-B331","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2337\/dc15-1817","article-title":"Diabetes and the association of postoperative hyperglycemia with clinical and economic outcomes in cardiac surgery","volume":"39","author":"Greco","year":"2016","journal-title":"Diabetes Care"},{"key":"2025110203540495200_ezx314-B332","doi-asserted-by":"crossref","first-page":"13.","DOI":"10.1007\/s11892-015-0583-8","article-title":"A comparison of inpatient glucose management guidelines: implications for patient safety and quality","volume":"15","author":"Mathioudakis","year":"2015","journal-title":"Curr Diab Rep"},{"key":"2025110203540495200_ezx314-B333","doi-asserted-by":"crossref","first-page":"1144.","DOI":"10.1016\/j.jtcvs.2005.05.049","article-title":"Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery","volume":"130","author":"Doenst","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203540495200_ezx314-B334","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/j.jvca.2011.12.016","article-title":"Intensive intraoperative insulin therapy versus conventional insulin therapy during cardiac surgery: a meta-analysis","volume":"26","author":"Hua","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203540495200_ezx314-B335","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mtc.2003.181","article-title":"Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting","volume":"125","author":"Furnary","year":"2003","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/53\/1\/5\/64102965\/ejcts_53_1_5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/53\/1\/5\/64102965\/ejcts_53_1_5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:54:44Z","timestamp":1762073684000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/53\/1\/5\/4360955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":335,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezx314","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,10,6]]}}}